Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AdaptHealth (AHCO) EPS (Weighted Average and Diluted) (2019 - 2025)

AdaptHealth has reported EPS (Weighted Average and Diluted) over the past 7 years, most recently at -$0.73 for Q4 2025.

  • Quarterly results put EPS (Weighted Average and Diluted) at -$0.73 for Q4 2025, down 314.71% from a year ago — trailing twelve months through Dec 2025 was -$0.52 (down 186.67% YoY), and the annual figure for FY2025 was -$0.52, down 185.25%.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.73 at AdaptHealth, down from $0.16 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for AHCO hit a ceiling of $0.4 in Q4 2021 and a floor of -$3.43 in Q3 2023.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was $0.09 (2022), compared with a mean of -$0.22.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): skyrocketed 200.0% in 2022 and later crashed 9600.0% in 2023.
  • AdaptHealth's EPS (Weighted Average and Diluted) stood at $0.4 in 2021, then plummeted by 105.0% to -$0.02 in 2022, then crashed by 9600.0% to -$1.94 in 2023, then soared by 117.53% to $0.34 in 2024, then crashed by 314.71% to -$0.73 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were -$0.73 (Q4 2025), $0.16 (Q3 2025), and $0.1 (Q2 2025) per Business Quant data.